SCHEMBL31578838

SCHEMBL31578838

CCOC(=O)Cc1csc(-c2ccc3cc[nH]c3c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ JAK2 O60674 1/20 0.48
▸ JAK3 P52333 1/20 0.48
▸ MAPT P10636 3/20 0.46
▸ CCNC P24863 1/20 0.46
▸ CDK8 P49336 1/20 0.46
▸ CDK19 Q9BWU1 1/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ GAA P10253 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ MAPK1 P28482 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ LMNA P02545 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31578879 0.88 SHMT2 (0.48) JAK2JAK3MAPTCCNCCDK8
SCHEMBL31578670 0.82 ALDH1A1 (0.60) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL3374076 0.81 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL31578780 0.80 ALDH1A1 (0.60) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL31578841 0.80 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL2073208 0.79 MAPT (0.65) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL4907597 0.79 LMNA (0.67) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11157975 0.79 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL6311629 0.79 MAPT (0.66) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL31578847 0.78 CYP19A1 (0.58) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163075-A1 HETEROBIFUNCTIONAL TARGETED PROTEIN DEGRADERS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163075-A1 HETEROBIFUNCTIONAL TARGETED PROTEIN DEGRADERS KLHDC2, KLHL6, KLHL20 MEN1 1833/4885KMT2A 253/4885JAK2 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback